---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-107409"
form_type: "8-K"
ticker: null
cik: "0001733413"
company_name: "TFF Pharmaceuticals, Inc."
filed_at: "2024-12-10T23:59:59+00:00"
generated_at: "2026-05-29T05:13:10.382725+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# TFF Pharmaceuticals receives Nasdaq delisting notice; trading to suspend Dec 13

## Summary
- On Dec 4, 2024, Nasdaq notified TFFP of delisting based on Plan of Dissolution, public interest concerns, and listing compliance issues.
- Trading of TFFP common stock will be suspended at the opening of business on December 13, 2024.
- Nasdaq will file Form 25-NSE with the SEC to remove the securities from listing and registration.
- Company states it does not intend to appeal the delisting determination.

## SEC filing metadata
- accession: 0001213900-24-107409
- form_type: 8-K
- cik: 0001733413
- company_name: TFF Pharmaceuticals, Inc.
- filed_at: 2024-12-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733413/000121390024107409/0001213900-24-107409-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733413/000121390024107409/ea0224167-8k_tffpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-107409
- JSON: https://secwatch.observer/filing/0001213900-24-107409.json
- Plain text: https://secwatch.observer/filing/0001213900-24-107409.txt

## Key facts
- Listing & Compliance Notices
  TFF Pharmaceuticals, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101, 5110(b)
  source text: December 4, 2024, TFF Pharmaceuticals, Inc. (“Company”) received a determination letter (the “Delisting Notification”) from the Nasdaq Stock Market (“Nasdaq”) stating that the Nasdaq staff determined, in accordance with Nasdaq Listing Rules 5101 and 5110(b) and Nasdaq Listing Rule IM 5101-1, that the Company’s common stock will be delisted from The Nasdaq Stock Market. The Delisting Notification states that the Nasdaq staff’s determination was based on (i) the Company’s previously announced Plan of Dissolution and associated public interest concerns raised by it; (ii) concerns regarding the re
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733413/000121390024107409/0001213900-24-107409-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.